Correction to: PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly
Adv Ther
.
2024 Jun;41(6):2531-2533.
doi: 10.1007/s12325-024-02829-6.
Authors
Dermot O'Toole
1
,
Pamela L Kunz
2
,
Susan M Webb
3
,
Grace Goldstein
4
,
Sheila Khawaja
5
,
Mark McDonnell
6
,
Sandra Boiziau
7
,
Delphine Gueguen
7
,
Aude Houchard
7
,
Antonio Ribeiro-Oliveira Jr
8
,
Ally Prebtani
9
Affiliations
1
Neuro Endocrine Tumours-ENETS Centre of Excellence, St. Vincent's University Hospital, Dublin, Ireland. OTOOLED1@tcd.ie.
2
Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA.
3
Departamento de Medicina/Endocrinología, Hospital Sant Pau, IIB-Sant Pau, Universitat Autònoma de Barcelona, CIBERER U747, Barcelona, Spain.
4
Carcinoid Cancer Foundation, Mount Kisco, NY, USA.
5
World Alliance of Pituitary Organizations, Zeeland, The Netherlands.
6
NET Patient Network Ireland, Dublin, Ireland.
7
Ipsen, Boulogne-Billancourt, France.
8
Ipsen, Cambridge, MA, USA.
9
Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
PMID:
38480663
DOI:
10.1007/s12325-024-02829-6
No abstract available
Publication types
Published Erratum